z-logo
Premium
Immunohistochemical and Ultrastructural Study of Langerhans's Cells in Squamous Cell Carcinoma of the Cervix
Author(s) -
Abdou Laila A.,
ElGazayerly Ibrahim M.,
ElShazley Laila Y.,
Zoheir Malak A.,
Kholeif Aly E.,
ElSedfy Amal S.
Publication year - 1999
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.1999.tb01116.x
Subject(s) - medicine , immunohistochemistry , ultrastructure , basal cell , cervix , pathology , carcinoma , cancer
Objective: To study Langerhans's cells (LCs) in cervical squamous cell carcinoma. Study design: The study was carried out in the Shatby University Hospital, Alexandria, Egypt. Thirty cases with squamous cell carcinoma, 10 cases with cervical intra‐epithelial neoplasia (CIN) and 10 cases with normal exocervix were recruited. Sections from the exocervix were stained with gold chloride, immunostaining with S‐100 protein antiserum, adenosine triphosphatase ATPase and electron microscopy. Statistical evaluation was done using the t ‐test. Results: Gold chloride staining revealed significantly increased number of LCs in all cases of CIN compared to normal controls and with increasing grade of CIN (p < ll 0.001). No relationship between LCs number and the grade of carcinoma. Least branched LCs were predominant in the normal tissue while in neoplasia, these cells were of the most branched type, indicating a hyperactivity. S‐100 protein positive LCs were almost absent in normal controls while their number were almost lower than the corresponding cases of CIN and invasive carcinoma after gold chloride or ATPase stainings. Signs of hyperactivity were evident in LCs of neoplastic cases after electron microscopy. Conclusions: Proliferation and increased number of LCs in CIN is an immune response, while such reaction is suppressed by invasive carcinoma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here